Page 13 - Be Limited News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biological E to Start Phase III Trial of Covid Vaccine Apr 25, 2021, 15:31 IST Biological E Limited (BE), a Hyderabad vaccine and pharmaceutical company based, announced that it has completed the Phase I/II clinical trial of its Covid-19 subunit vaccine candidate in India and has obtained approval from the Central Drugs Standard Control Organization (CDSCO) – Subject Expert Committee to begin the phase III clinical trial (SEC).  The phase III clinical trial, which will be conducted at 15 locations across India, will test the immunogenicity and safety of Biological E's SARS-CoV-2 Co...

Read more about Biological E to start phase 3 clinical trials of its Covid-19 vaccine soon on Business Standard. The phase III clinical study, to be conducted in 15 sites across India, will evaluate the immunogenicity and safety of Biological E's vaccine candidate in 1,268 healthy subjects

Biological E Covid vaccine candidate gets CDSCO nod for Phase III trials ​ By IANS | ​ 8 Views Only 4% beneficiaries turn up for 2nd dose of Covid vaccine. Image Source: IANS News Hyderabad, April 24 : Hyderabad-based vaccine and pharmaceutical company Biological E. Limited (BE) announced on Saturday that its Covid-19 subunit vaccine candidate has received approval to begin Phase III clinical trials in India. A statement issued by the company said that it has received clearance from the subject expert committee (SEC) of Central Drugs Standard Control Organisation (CDSCO) following the s...

Photo Credit: IANS IANSLive Hyderabad, April 24 (IANS) Hyderabad-based vaccine and pharmaceutical company Biological E. Limited (BE) announced on Saturday that its Covid-19 subunit vaccine candidate has received approval to begin Phase III clinical trials in India. To get full access of the story, click here to subscribe to IANS News Service © 2021 IANS India Private Limited. All Rights Reserved. The reproduction of the story/photograph in any form will be liable for legal action. For news, views and gossips, follow IANS at Twitter. Update: 24-April-2021

Biological E to begin phase 3 trials for COVID-19 vaccine By Yunus Y Lasania|   Published: 24th April 2021 5:24 pm IST Hyderabad: Hyderabad-based vaccine and pharmaceutical company Biological E. Limited (BE) today announced that it has successfully completed the phase I/II clinical trials of its COVID-19 subunit vaccine candidate in India. The company has also received approval to start phase III clinical trials from the Central Drugs Standard Control Organization (CDSCO) – Subject Expert Committee (SEC). The phase III clinical study to be conducted in 15 sites across India, and will eval...